Page last updated: 2024-10-26

diclofenac and Carcinoma, Renal Cell

diclofenac has been researched along with Carcinoma, Renal Cell in 2 studies

Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.

Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Thai, KJ1
Ralph, C1
England, D1
Yanaihara, H1
Nakazono, M1
Tsunoda, S1

Other Studies

2 other studies available for diclofenac and Carcinoma, Renal Cell

ArticleYear
Treatment of Cabozantinib-Related Palmar-Plantar Erythrodysesthesia With Topical Sildenafil, Diclofenac, and Gabapentin Cream: A Case Report.
    JCO oncology practice, 2020, Volume: 16, Issue:3

    Topics: Administration, Cutaneous; Aged; Anilides; Carcinoma, Renal Cell; Diclofenac; Gabapentin; Hand-Foot

2020
[A case of drug-induced immune hemolytic anemia during alpha-interferon therapy for renal cell carcinoma].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 1996, Volume: 87, Issue:3

    Topics: Anemia, Hemolytic, Autoimmune; Carcinoma, Renal Cell; Diclofenac; Female; Humans; Indomethacin; Inte

1996